Company: MYSEW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004290
Chunk: 1364

Company: Myseum, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9A
Chunk 1364
---
 2023. Proportional
adjustments for the Reverse Stock Split were made to the Company’s outstanding stock options, warrants and equity incentive plans,
and authorized shares.

On November 9, 2023, the Company filed a Certificate
of Correction with the Secretary of State of the State of Nevada to correct a typographical error contained in the Certificate of Change
that was filed with the Secretary of State of the State of Nevada on September 19, 2023 in order to effectuate the Reverse Stock Split.
The Certificate of Change incorrectly stated that the authorized shares of preferred stock, par value $0.0001 per share following the
change was 1,000,000. The Reverse Stock Split had no impact on the number of authorized shares of preferred, par value $0.0001, which
remains unchanged at 20,000,000 shares.

On December 27, 2023, the Company filed a Certificate
of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to increase the number of authorized
common stock from 18,000,000 shares to 180,000,000 shares.

All share and per-share data and amounts have
been retroactively adjusted as of the earliest period presented in the consolidated financial statements to reflect the Reverse Stock
Split.

The authorized capital stock consists of 200,000,000
shares, of which 180,000,000 are shares of common stock and 20,000,000 are shares of preferred stock.

2021 Omnibus Equity Incentive Plan

On July 26, 2021, the Company adopted the 2021
Omnibus Equity Incentive Plan (the “2021 Equity Plan”) and authorized the reservation of 200,000 shares of common stock for
future issuances under the 2021 Equity Plan. The 2021 Equity Plan provides that the Company may grant options, stock appreciation rights,
restricted stock, restricted stock units, other stock-based awards or any combination of the foregoing. On December 19, 2022, the Company
held its 2022 annual meeting of stockholders, and the shareholders approved to amend the 2021 Equity Plan to increase the number of shares
reserved for issuances thereunder to 300,000 shares from 200,000. On November 10, 2023, the board of directors of the Company approved
the adoption of the Amended and Restated 2021 Equity Plan, the